The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation
Abstract
Most human cancers acquire mutations causing defects in the p53 signaling pathway. The tumor suppressor p53 becomes activated in response to genotoxic stress and is essential for arresting the cell cycle to facilitate DNA repair or to initiate apoptosis. p53-induced cell cycle-arrest is mediated by expression of the CDK inhibitor p21WAF1/Cip1, which prevents phosphorylation and inactivation of the pocket proteins RB, p130, and p107. In a hypophosphorylated state, pocket proteins bind to E2F factors forming RB-E2F and DREAM transcriptional repressor complexes. Here, we analyze the influence of RB and DREAM on p53-induced gene repression and cell-cycle arrest. We show that abrogation of DREAM function by knockout of the DREAM component LIN37 results in a reduced repression of cell-cycle genes. We identify the genes repressed by the p53-DREAM pathway and describe a set of genes that is downregulated by p53 independent of LIN37/DREAM. Most strikingly, p53-dependent repression of cell-cycle genes is completely abrogated in LIN37−/−;RB−/− cells leading to a loss of the G1/S checkpoint. Taken together, we show that DREAM and RB are key factors in the p53 signaling pathway to downregulate a large number of cell-cycle genes and to arrest the cell cycle at the G1/S transition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This transcriptional repression is indirect because p53 does not bind to regulatory elements in the concerned genes. Still, it requires p21, which is a key element in the p53‐p21 DREAM pathway [71, 73, 74].”
From The TP53 tumor suppressor gene: From molecular biology to clinical investigations (2025) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Accurate whole human genome sequencing using reversible terminator chemistry
Bentley, D. R., Balasubramanian, S., Swerdlow, H. P., Smith, G. P., Milton, J., Brown, C. G., Hall, K. P., Evers, D. J., Barnes, C. L., Bignell, H. R., et al. (2008) · Nature · doi:10.1038/nature07517 · Cited by 3,684
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Treating cancer with selective CDK4/6 inhibitors
O'Leary, B., Finn, R. S., & Turner, N. C. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.26 · Cited by 1,137
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Self-citationTargeted disruption of the three Rb-related genes leads to loss of G 1 control and immortalization
Sage, J., Mulligan, G. J., Attardi, L. D., Miller, A., Chen, S., Williams, B., Theodorou, E., & Jacks, T. (2000) · Genes & Development · doi:10.1101/gad.843200 · Cited by 582
The DREAM complex: master coordinator of cell cycle-dependent gene expression
Sadasivam, S., & DeCaprio, J. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3556 · Cited by 524
Hurford, R. K., Cobrinik, D., Lee, M. H., & Dyson, N. (1997) · Genes & Development · doi:10.1101/gad.11.11.1447 · Cited by 431
Dannenberg, J.-H., van Rossum, A., Schuijff, L., & te Riele, H. (2000) · Genes & Development · doi:10.1101/gad.847700 · Cited by 413
Research works printed but not linked: 51
- Kastenhuber, 2017, Putting p53 in Context, Cell, 170, 1062, 10.1016/j.cell.2017.08.028 · DOI · Paper page
- Fischer, 2016, Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks, Nucleic Acids Res., 44, 6070, 10.1093/nar/gkw523 · DOI · Paper page
- Engeland, 2018, Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM, Cell Death Differ., 25, 114, 10.1038/cdd.2017.172 · DOI · Paper page
- Nguyen, 2018, Revealing a human p53 universe, Nucleic Acids Res., 46, 8153, 10.1093/nar/gky720 · DOI
- Fischer, 2014, The transcription factor p53: not a repressor, solely an activator, Cell Cycle, 13, 3037, 10.4161/15384101.2014.949083 · DOI · Paper page
- Quaas, 2012, p53 can repress transcription of cell cycle genes through a p21(WAF1/CIP1)-dependent switch from MMB to DREAM protein complex binding at CHR promoter elements, Cell Cycle, 11, 4661, 10.4161/cc.22917 · DOI · Paper page
- Dulic, 1994, p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest, Cell, 76, 1013, 10.1016/0092-8674(94)90379-4 · DOI · Paper page
- Harper, 1993, The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases, Cell, 75, 805, 10.1016/0092-8674(93)90499-G · DOI · Paper page
- Harper, 1995, Inhibition of cyclin-dependent kinases by p21, Mol. Biol. Cell, 6, 387, 10.1091/mbc.6.4.387 · DOI · Paper page
- Sherr, 1995, Inhibitors of mammalian G1 cyclin-dependent kinases, Genes Dev., 9, 1149, 10.1101/gad.9.10.1149 · DOI · Paper page
- Beijersbergen, 1995, Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes, Genes Dev., 9, 1340, 10.1101/gad.9.11.1340 · DOI · Paper page
- Bruce, 2000, Requirements for cell cycle arrest by p16INK4a, Mol. Cell, 6, 737, 10.1016/S1097-2765(00)00072-1 · DOI
- Helin, 1992, A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F, Cell, 70, 337, 10.1016/0092-8674(92)90107-N · DOI · Paper page
- Lees, 1993, The retinoblastoma protein binds to a family of E2F transcription factors, Mol. Cell Biol., 13, 7813, 10.1128/MCB.13.12.7813 · DOI · Paper page
- Liban, 2017, Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family, Proc. Natl. Acad. Sci. U.S.A., 114, 4942, 10.1073/pnas.1619170114 · DOI
- Liban, 2016, Structural conservation and E2F binding specificity within the retinoblastoma pocket protein family, J. Mol. Biol., 428, 3960, 10.1016/j.jmb.2016.08.017 · DOI
- Pilkinton, 2007, Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex, Oncogene, 26, 7535, 10.1038/sj.onc.1210562 · DOI
- Guiley, 2015, Structural mechanisms of DREAM complex assembly and regulation, Genes Dev., 29, 961, 10.1101/gad.257568.114 · DOI
- Müller, 2016, Timing of transcription during the cell cycle: Protein complexes binding to E2F, E2F/CLE, CDE/CHR, or CHR promoter elements define early and late cell cycle gene expression, Oncotarget, 8, 97736, 10.18632/oncotarget.10888 · DOI · Paper page
- Müller, 2012, The CHR promoter element controls cell cycle-dependent gene transcription and binds the DREAM and MMB complexes, Nucleic Acids Res., 40, 1561, 10.1093/nar/gkr793 · DOI
- Müller, 2014, The CHR site: definition and genome-wide identification of a cell cycle transcriptional element, Nucleic Acids Res., 42, 10331, 10.1093/nar/gku696 · DOI
- Forristal, 2014, Loss of the mammalian DREAM complex deregulates chondrocyte proliferation, Mol. Cell Biol., 34, 2221, 10.1128/MCB.01523-13 · DOI
- Iness, 2018, The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb, Oncogene, 38, 1080, 10.1038/s41388-018-0490-y · DOI
- Mages, 2017, The DREAM complex through its subunit Lin37 cooperates with Rb to initiate quiescence, Elife., 6, e26876, 10.7554/eLife.26876 · DOI
- Classon, 2000, Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control, Proc. Natl. Acad. Sci. U.S.A., 97, 10820, 10.1073/pnas.190343497 · DOI
- Uphoff, 2002, Detection of mycoplasma in leukemia-lymphoma cell lines using polymerase chain reaction, Leukemia, 16, 289, 10.1038/sj.leu.2402365 · DOI
- Ran, 2013, Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity, Cell, 154, 1380, 10.1016/j.cell.2013.08.021 · DOI · Paper page
- Kirschner, 2008, Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site, Nucleic Acids Res., 36, 2969, 10.1093/nar/gkn132 · DOI
- Tavner, 2007, Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells, Oncogene, 26, 2727, 10.1038/sj.onc.1210087 · DOI
- Martin, 2011, Cutadapt removes adapter sequences from high-throughput sequencing reads, EMBnet j., 17, 10, 10.14806/ej.17.1.200 · DOI · Paper page
- Hoffmann, 2014, A multi-split mapping algorithm for circular RNA, splicing, trans-splicing and fusion detection, Genome Biol., 15, R34, 10.1186/gb-2014-15-2-r34 · DOI · Paper page
- Liao, 2014, featureCounts: an efficient general purpose program for assigning sequence reads to genomic features, Bioinformatics, 30, 923, 10.1093/bioinformatics/btt656 · DOI · Paper page
- Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol., 15, 550, 10.1186/s13059-014-0550-8 · DOI · Paper page
- Huang, 2009, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat. Protoc., 4, 44, 10.1038/nprot.2008.211 · DOI · Paper page
- Benson, 2014, p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes, Oncogene, 33, 3959, 10.1038/onc.2013.378 · DOI · Paper page
- Helin, 1993, Heterodimerization of the transcription factors E2F-1 and Dp-1 leads to cooperative transactivation, Genes & Development, 7, 1850, 10.1101/gad.7.10.1850 · DOI · Paper page
- Flemington, 1993, E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product, Proc. Natl. Acad. Sci. U.S.A., 90, 6914, 10.1073/pnas.90.15.6914 · DOI · Paper page
- Helmbold, 2009, Rb2/p130 is the dominating pocket protein in the p53-p21 DNA damage response pathway leading to senescence, Oncogene, 28, 3456, 10.1038/onc.2009.222 · DOI
- Herrera, 1996, TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein, Mol. Biol. Cell, 7, 1335, 10.1091/mbc.7.9.1335 · DOI
- Herrera, 1996, Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts, Mol. Cell Biol., 16, 2402, 10.1128/MCB.16.5.2402 · DOI · Paper page
- Schade, 2019, Cyclin D–CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB, Oncogene, 26, 539
- Marceau, 2016, Structural basis for LIN54 recognition of CHR elements in cell cycle-regulated promoters, Nat. Commun., 7, 12301, 10.1038/ncomms12301 · DOI
- Broude, 2007, p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation, Oncogene, 26, 6954, 10.1038/sj.onc.1210516 · DOI
- Uchida, 2005, Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation, EMBO J., 24, 160, 10.1038/sj.emboj.7600486 · DOI · Paper page
- Liu, 2019, MDM2-mediated degradation of WRN promotes cellular senescence in a p53-independent manner, Oncogene, 38, 2501, 10.1038/s41388-018-0605-5 · DOI
- Lin, 1994, Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest, Proc. Natl. Acad. Sci. U.S.A., 91, 10079, 10.1073/pnas.91.21.10079 · DOI
- Tacar, 2013, Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems, J. Pharm. Pharmacol., 65, 157, 10.1111/j.2042-7158.2012.01567.x · DOI · Paper page
- Matsuoka, 1998, Linkage of ATM to cell cycle regulation by the Chk2 protein kinase, Science, 282, 1893, 10.1126/science.282.5395.1893 · DOI · Paper page
- Harrington, 1998, pRB plays an essential role in cell cycle arrest induced by DNA damage, Proc. Natl. Acad. Sci. U.S.A., 95, 11945, 10.1073/pnas.95.20.11945 · DOI · Paper page
- Talluri, 2012, Regulation of transcription and chromatin structure by pRB: here, there and everywhere, Cell Cycle, 11, 3189, 10.4161/cc.21263 · DOI
- Stewart-Ornstein, 2016, Dynamics of CDKN1A in single cells defined by an endogenous fluorescent tagging toolkit, Cell Rep., 14, 1800, 10.1016/j.celrep.2016.01.045 · DOI
Cited by
The TP53 tumor suppressor gene: From molecular biology to clinical investigations
Baliakas, P., & Soussi, T. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20106 · Cited by 50
Metadata
- Authors
- Uxa, S., Bernhart, S. H., Mages, C. F. S., Fischer, M., Kohler, R., Hoffmann, S., Stadler, P. F., Engeland, K., & Müller, G. A.
- Affiliations
- Molecular Oncology, Department of Gynaecology, Medical School, Leipzig University, 04103 Leipzig, Germany
- Transcriptome Bioinformatics Group, Department of Computer Science and Interdisciplinary Center for Bioinformatics, Leipzig University, 04107 Leipzig, Germany
- Computational Biology Group, Leibniz Institute on Aging – Fritz Lipmann Institute (FLI), 07745 Jena, Germany
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-08-10
- Volume
- 47
- Issue
- 17
- Pages
- 9087-9103
- ISSN
- 0305-1048
- 1362-4962
- Cited by
- 117
- References
- 19
- Language
- en
- Funders
- German Research Foundation (MU 3798/1-1)
- MF (FI 1993/2-1)
- German BMBF (01KU1505-C)
- University of Leipzig
- German Academic Scholarship Foundation
- Christiane Nüsslein-Volhard Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation. https://app.cochat.ai/papers/10.1093/nar/gkz635
- The paper
- Uxa, S., Bernhart, S. H., Mages, C. F. S., Fischer, M., Kohler, R., Hoffmann, S., Stadler, P. F., Engeland, K., & Müller, G. A. (2019). DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation. Nucleic Acids Research. https://doi.org/10.1093/nar/gkz635
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.